Pneumonia remains a leading cause of mortality internationally, making it an intense area of study for new tools for diagnosis and treatment. In this review, we evaluate the potential of recently emerging syndromic panels in promoting rapid diagnosis and improved antibiotic stewardship. We will also examine emerging treatments, including new antibiotics in a world of worsening antimicrobial resistance, in addition to new methods of delivery and non-antibiotic paths of treatment.